Business Information
The group's principal activities are to design, manufacture and market ultrasonic medical devices. The group also develops and markets ultrasonic equipment for use in the scientific and industrial markets, ductless fume enclosures for filtration of gaseous contaminates and environmental control products for the abatement of air pollution. The group operates through two segments: medical devices segment manufactures and sells the auto sonix ultrasonic cutting and coagulatory system, ultrasound systems and replacement transducers for the medical diagnostic ultrasound industry, ultrasonic lithotriptor, ultrasonic neuroaspirator (used for neurosurgery) and soft tissue aspirator and laboratory and scientific products segment manufactures and sells sonicator(R) ultrasonic liquid processors and cell disruptors, aura(tm) ductless fume hood products and mystaire(R) scrubbers for the abatement of air pollution.
|
|
Name |
Title
|
Email
|
| Michael McManus | Dir., CEO, Pres. | N/A | | Richard Zaremba | CFO, Sr. VP | N/A | | Dan Voic | VP - Research, Development, Engineering | N/A | | Frank Napoli | VP - Operations | N/A | | Ronald Manna | VP - Regulatory Affairs | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 39,067 | (3,759) | | 2005 | 45,907 | 936 | | 2004 | 39,059 | 1,719
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
